Biomaterials and Regenerative Medicine
Head of the Center: Dr. Michal Goldenberg and Dr. Kfir Ben Harush
The global biomaterials market is one of the largest and most significant markets, receiving widespread recognition amongst numerous companies and entities, largely due to the rapidly developing field of tissue engineering and the demand for materials for medical applications.
These fields require a search for materials with extensive biological compatibility. Natural materials provide one of the alternatives for these needs, due to their unique qualities. Natural materials such as proteins (silk, keratin, collagen, elastin, and others), polysaccharides (cellulose, chitin, alginate and others), and minerals (silica, hydroxylapatite, and others) make up the majority of biological materials in nature, and they have a mechanical and functional role in various biological systems.
Among the biological materials, protein-based materials are an exceptional option, due to their ability to modify the building blocks (amino acids), giving these materials the required mechanical qualities.
In this research, we use the family of intermediate filament proteins, which protect the biological cells in various tissues against pressing and stretching exertion, thus maintaining the cell’s unity during activity and movement. Due to this crucial mechanical role, intermediate filament proteins have unique mechanical qualities that combine strength and elasticity; however, these proteins have not been researched extensively as potential building blocks for producing biomaterials for the medical field.
The Research Center for Biomaterials and Regenerative Medicine has defined its vision - to focus on the production, planning and development of “smart” biomaterials – materials with unique qualities that provide them with advantages when used in designated tissues.
Dr. Michal Goldenberg
Dr. Kfir Ben Harush